Analyse des écarts et soutien réglementaire en vue du premier essai sur l’homme (FIH) prévu en Europe

Marketing Communication
Regulatory affairs Pharmaceutical industry
Regulatory affairs Pharmaceutical industry
20 novembre 2018
image_pdfPDF

Un client basé aux États-Unis a contacté BlueReg (BR) pour obtenir de l’aide dans l’examen du CMC et du paquet de développement non clinique en vue d’un essai clinique de la FIH qui sera mené en Europe.

Download the
Case Study

    By sending this form, I agree that my personal data will be saved and processed according to data protection regulations and will be used only for commercial and marketing purposes only.

    Learn more


    BlueReg undertakes to comply with the regulations in force applicable to the processing of personal data and, in particular, Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 applicable as from 25 May 2018 (hereinafter, "the General Data Protection Regulations" or GPDR) and the national laws resulting therefrom.
    Any inquiries, correction or declaration of event related to personal data processed should be sent to: GDPR data request

    GDPR data request

    Merci de l'intérêt que vous portez à BlueReg.


    Le document vous sera envoyé par email.

    Téléchargez votre Case study